ATRA与BMP9对人骨肉瘤细胞增殖及分化作用的研究

吴念; 张平; 田冬冬; 张然熙; 陈前昭; 何百成; 尹良军

doi:10.16016/j.1000-5404.201610139

您当前的位置：

首页 >

文章列表页 >

ATRA与BMP9对人骨肉瘤细胞增殖及分化作用的研究

基础医学 | 更新时间：2026-01-09

- ATRA与BMP9对人骨肉瘤细胞增殖及分化作用的研究
- Effects of all-trans-retinoic acid and bone morphogenetic protein 9 on proliferation and differentiation of human osteosarcoma cells
- 第三军医大学学报 2017年39卷第13期页码：1333-1338
- 作者机构：
  
  1.400010 重庆，重庆医科大学附属第二医院骨科
  2.400016 重庆，重庆市生物化学与分子药理学重点实验室
  3.400016 重庆，重庆医科大学药学院药理学教研室
- 作者简介：
  
  [ 尹良军，E-mail:albertyin@163.com YIN Liangjun, E-mail:albertyin@163.com
- 基金信息：
  
  国家自然科学基金面上项目(81572226)
- DOI：10.16016/j.1000-5404.201610139
  中图分类号： R34;R730.23;R738.1
- 收稿：2016-10-21，
  
  修回：2016-12-07，
  
  纸质出版：2017-07-15
- 稿件说明：
移动端阅览
吴念, 张平, 田冬冬, 等. ATRA与BMP9对人骨肉瘤细胞增殖及分化作用的研究[J]. 第三军医大学学报, 2017,39(13):1333-1338.

Nian WU, Ping ZHANG, Dongdong TIAN, et al. Effects of all-trans-retinoic acid and bone morphogenetic protein 9 on proliferation and differentiation of human osteosarcoma cells[J]. Journal of Third Military Medical University, 2017, 39(13): 1333-1338.
吴念, 张平, 田冬冬, 等. ATRA与BMP9对人骨肉瘤细胞增殖及分化作用的研究[J]. 第三军医大学学报, 2017,39(13):1333-1338. DOI： 10.16016/j.1000-5404.201610139.

Nian WU, Ping ZHANG, Dongdong TIAN, et al. Effects of all-trans-retinoic acid and bone morphogenetic protein 9 on proliferation and differentiation of human osteosarcoma cells[J]. Journal of Third Military Medical University, 2017, 39(13): 1333-1338. DOI： 10.16016/j.1000-5404.201610139.

摘要

目的

研究全反式维甲酸(all-trans-retinoic acid，ATRA)与骨形态发生蛋白9(bone morphogenetic proteins 9，BMP9) 对人骨肉瘤细胞增殖及分化的影响。

方法

利用四甲基偶氮唑蓝(MTT)法和流式细胞仪分析细胞增殖情况；蛋白质免疫印迹实验(Western blot)检测细胞增殖和成骨相关指标；半定量PCR及Western blot分析ATRA和ATRA与BMP9联用处理143B细胞株后对BMP9表达水平的影响。

结果

在人骨肉瘤143B细胞株中，与对照组相比，ATRA能明显抑制细胞增殖(

0.05)，并促使细胞周期阻滞在G

期(

0.05)，下调PCNA的蛋白水平，并呈浓度依赖性；ATRA能呈浓度依赖性增加晚期成骨指标OCN和OPN的蛋白水平(

0.05)；ATRA能上调BMP9的mRNA及蛋白水平，并呈浓度依赖性(

0.05)；单用BMP9并不能上调OCN和OPN表达，并促进其增殖(

0.05)，但与ATRA联用时，能够增强ATRA诱导的相关成骨指标表达和抗增殖作用(

0.05)。

结论

ATRA对143B细胞的增殖具有抑制作用并诱导其成骨分化，并可能恢复BMP9的成骨诱导能力。

Abstract

Objective

To determine the effects of all-trans-retinoic acid (ATRA) and bone morphogenetic protein 9 (BMP9) on the proliferation and osteogenic differentiation of human osteosarcoma (OS) cells.

Methods

MTT assay and flow cytometry were used to analyze the proliferation of the human OS cell line 143B. Western blot analysis was used to detect the proliferation-and osteogenesis-related markers. Semi-quantitative PCR and Western blot analysis were used to analyze the expression levels of BMP9 in 143B cells after treated with ATRA alone or combined with BMP9.

Results

In the 143B cells

ATRA significantly inhibited the proliferation of 143B cells (

0.05) compared with the untreated group

promoted cell cycle arrested in G1 phase (

0.05)

and reduced the pro

tein level of PCNA in

concentration-dependent manner. The protein levels of lately osteogenic makers OPN and OCN were up-regulated by ATRA treatment in

concentration-dependent manner (

0.05)

so were the mRNA and protein levels of endogenous BMP9 (

0.05). BMP9 alone failed to up-regulate the expression of OPN and OCN but promoted the proliferation of 143B cells (

0.05)

but when combined with ATRA

BMP9 enhanced the expression of osteogenic markers and anti-proliferation effect induced by ATRA (

0.05).

Conclusion

ATRA inhibit the proliferation and induce osteogenic differentiation in 143B cells

and may restore the osteogenic capability of BMP9.

关键词

Keywords

references

HELMAN L J, MELTZER P. Mechanisms of sarcoma development[J]. Nat Rev Cancer, 2003, 3(9): 685-694.DOI:10.1038/nrc1168.

BIELACK S S, CARRLE D, HARDES J, et al. Bone tumors in adolescents and young adults[J]. Curr Treat Options Oncol, 2008, 9(1): 67-80.DOI:10.1007/s11864-008-0057-1.

GENG S, SUN B, LU R, et al. Coleusin factor, a novel anticancer diterpenoid, inhibits osteosarcoma growth by inducing bone morphogenetic protein-2-dependent differentiation[J]. Mol Cancer Ther, 2014, 13(6): 1431-1441.DOI:10.1158/1535-7163.MCT-13-0934.

LUO X, CHEN J, SONG W X, et al. Osteogenic bmps promote tumor growth of human osteosarcomas that harbor differentiation defects[J]. Lab Invest, 2008, 88(12): 1264-1277.DOI: 10.1038/labinvest.2008.98.

CLAGETT-DAME M, KNUTSON D. Vitamin A in reproduction and development[J]. Nutrients, 2011, 3(4): 385-428.DOI: 10.3390/nu3040385.

ATASHRAZM F, LOWENTHAL R M, DICKINSON J L, et al. Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo [J ] . Oncotarget, 2016. [Epub ahead of print ] .DOI: 10.18632/oncotarget.10016.

SILVIS A M, MCCORMICK M L, SPITZ D R, et al. Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid[J]. Redox Biol, 2016, 7: 88-96.DOI: 10.1016/j.redox.2015.11.012.

YAN Y W, LI Z, XU X, et al. All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy[J]. BMC Complement Alter Med, 2016, 16:113.DOI: 10.1186/s12906-016-1088-y.

AMANN P M,CZAJA K, BAZHIN A V, et al. Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells[J]. Exp Dermatol, 2014, 23(11): 832-837.DOI: 10.1111/exd.12548.

YANG Q J, ZHOU L Y, MU Y Q, et al. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation[J]. Int J Oncol, 2012, 41(1): 153-160. DOI: 10.3892/ijo.2012.1426.

ZHANG L, ZHOU Q, ZHANG N, et al. E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα[J ] . Cell cycle, 2014, 13(8): 1277-1287.DOI: 10.4161/cc.28190.

DUAN L, YE L, WU R, et al. Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells[J]. J Cell Biochem, 2015, 116(6): 1080-1089.DOI: 10.1002/jcb.25063.

黄帆, 刘映孜, 杨秋琚, 等.全反式维甲酸增强骨形态蛋白9诱导间充质干细胞成骨分化作用[J].第三军医大学学报, 2013, 35(4): 328-331.DOI: 10.16016/j.1000-5404.2013.04.025.

HUANG F, LIU Y Z, YANG Q J, et al. All-trans retinoic acid enhances BMP9-induced osteogenic differentiation in mesenchymal stem cells[J]. J Third Mil Med Univ, 2013, 35(4): 328-331.DOI: 10.16016/j.1000-5404.2013.04.025.

LIU Y, LIU Y, ZHANG R, et al. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways[J]. Int J Biochem Cell Biol, 2014, 47:47-56.DOI: 10.1016/j.biocel.2013.11.018.

TANG N, SONG W X, LUO J, et al. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling[J]. J Cell Mol Med, 2009, 13(8B): 2448-2464. DOI:10.1111/j.1582-4934.2008.00569.x.

DILWORTH F J, CHAMBON P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription[J]. Oncogene, 2001, 20(24): 3047-3054.DOI: 10.1038/sj.onc.1204329.

RUIJTENBERG S, VAN DEN HEUVEL S. Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression[J]. Cell cycle, 2016, 15(2): 196-212.DOI: 10.1080/15384101.2015.1120925.

LV Z, WANG C, YUAN T, et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway[J]. Oncol Rep, 2014, 31(2): 989-994.DOI: 10.3892/or.2013.2931.

LI R, ZHANG W, CUI J, et al. Targeting BMP9-promoted human osteosarcoma growth by inactivation of Notch signaling[J]. Curr Cancer Drug Targets, 2014, 14(3): 274-285. DOI:DOI: 10.2174/1568009614666140305105805.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

MiR-616在骨肉瘤中的表达及对其细胞增殖、凋亡、迁移侵袭的作用

下调Notch3表达对骨肉瘤细胞生物学特性的影响

全反式维甲酸对小鼠黑色素瘤B16F10细胞生物学行为的影响

冬凌草甲素促进骨肉瘤细胞143B凋亡及其可能机制

RanBP9的表达对骨肉瘤细胞增殖、凋亡及转移的影响